{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T19:30:08Z","timestamp":1781033408291,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00347-022-01750-z","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T17:03:36Z","timestamp":1668099816000},"page":"1121-1128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Isch\u00e4mie und Lasertherapie bei retinalen ven\u00f6sen Verschl\u00fcssen","Ischemia and laser photocoagulation in retinal vein occlusion"],"prefix":"10.1007","volume":"119","author":[{"given":"Matus","family":"Rehak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Werner","family":"Storch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars-Olof","family":"Hattenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Feltgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"issue":"6","key":"1750_CR1","doi-asserted-by":"publisher","first-page":"1022\u201330","DOI":"10.1016\/j.ajo.2009.01.009","volume":"147","author":"M Bonini-Filho","year":"2009","unstructured":"Bonini-Filho\u00a0M, Costa\u00a0RA, Calucci\u00a0D et al (2009) Intravitreal bevacizumab for diabetic macular edema associated with severe capillary loss: one-year results of a\u00a0pilot study. Am J Ophthalmol 147(6):1022\u201330\u20131021030.e1. https:\/\/doi.org\/10.1016\/j.ajo.2009.01.009","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"1750_CR2","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1001\/archopht.120.12.1644","volume":"120","author":"SR Boyd","year":"2002","unstructured":"Boyd\u00a0SR, Zachary\u00a0I, Chakravarthy\u00a0U et\u00a0al (2002) Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion. Arch Ophthalmol 120(12):1644\u20131650. https:\/\/doi.org\/10.1001\/archopht.120.12.1644","journal-title":"Arch Ophthalmol"},{"issue":"1986","key":"1750_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1001\/archopht.1986.01050130044017","volume":"104","author":"Branch Vein Occlusion Study Group","year":"1986","unstructured":"Branch Vein Occlusion Study Group (1986) Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion: a\u00a0randomized clinical trial. Arch Ophthalmol 104(1986):34\u201341. https:\/\/doi.org\/10.1001\/archopht.1986.01050130044017","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"1750_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0002-9394(84)90316-7","volume":"15;98","author":"Branch Vein Occlusion Study Group","year":"1984","unstructured":"Branch Vein Occlusion Study Group (1984) Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 15;98(3):271\u2013282. https:\/\/doi.org\/10.1016\/0002-9394(84)90316-7","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"1750_CR5","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1007\/s00347-018-0775-0","volume":"115","author":"BVA, DOG & RG","year":"2018","unstructured":"BVA, DOG & RG (2018) Stellungnahme von BVA, DOG und RG zur intravitrealen Therapie des visusmindernden Makula\u00f6dems bei retinalem Venenverschluss: Therapeutische Strategien, Stand 24.04.2018. Ophthalmologe 115(10):842\u2013854. https:\/\/doi.org\/10.1007\/s00347-018-0775-0 (German)","journal-title":"Ophthalmologe"},{"issue":"5","key":"1750_CR6","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00417-018-04223-9","volume":"257","author":"J Callizo","year":"2019","unstructured":"Callizo\u00a0J, Atili\u00a0A, Striebe\u00a0NA et al (2019) Bevacizumab versus bevacizumab and macular grid photocoagulation for macular edema in eyes with non-ischemic branch retinal vein occlusion: results from a\u00a0prospective randomized study. Graefes Arch Clin Exp Ophthalmol 257(5):913\u2013920. https:\/\/doi.org\/10.1007\/s00417-018-04223-9","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"1750_CR7","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.ophtha.2015.04.006","volume":"122","author":"PA Campochiaro","year":"2015","unstructured":"Campochiaro\u00a0PA, Hafiz\u00a0G, Mir\u00a0TA et\u00a0al (2015) Scatter photocoagulation does not reduce macular edema or treatment burden in patients with retinal vein occlusion: the RELATE trial. Ophthalmology 122(7):1426\u20131437. https:\/\/doi.org\/10.1016\/j.ophtha.2015.04.006","journal-title":"Ophthalmology"},{"issue":"1","key":"1750_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ophtha.2013.08.038","volume":"121","author":"PA Campochiaro","year":"2014","unstructured":"Campochiaro\u00a0PA, Sophie\u00a0R, Pearlman\u00a0J, RETAIN Study Group (2014) Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study. Ophthalmology 121(1):209\u2013219. https:\/\/doi.org\/10.1016\/j.ophtha.2013.08.038","journal-title":"Ophthalmology"},{"issue":"1997","key":"1750_CR9","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1001\/archopht.1997.01100150488006","volume":"115","author":"Central Vein Occlusion Study Group","year":"1997","unstructured":"Central Vein Occlusion Study Group (1997) Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 115(1997):486\u2013491. https:\/\/doi.org\/10.1001\/archopht.1997.01100150488006","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"1750_CR10","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0161-6420(95)30848-2","volume":"102","author":"Central Vein Occlusion Study Group","year":"1995","unstructured":"Central Vein Occlusion Study Group (1995) A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report. Ophthalmology 102(10):1434\u20131444 (PMID: 9097789)","journal-title":"Ophthalmology"},{"issue":"11","key":"1750_CR11","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1097\/IAE.0000000000000859","volume":"35","author":"A Couturier","year":"2015","unstructured":"Couturier\u00a0A, Man\u00e9\u00a0V, Bonnin\u00a0S et\u00a0al (2015) Capillary plexus anomalies in diabetic retinopathy on optical coherence tomography angiography. Retina 35(11):2384\u20132391. https:\/\/doi.org\/10.1097\/IAE.0000000000000859","journal-title":"Retina"},{"issue":"9","key":"1750_CR12","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1136\/bjophthalmol-2019-315192","volume":"104","author":"VA Eng","year":"2020","unstructured":"Eng\u00a0VA, Leng\u00a0T (2020) Subthreshold laser therapy for macular oedema from branch retinal vein occlusion: focused review. Br J Ophthalmol 104(9):1184\u20131189. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-315192","journal-title":"Br J Ophthalmol"},{"key":"1750_CR13","doi-asserted-by":"publisher","first-page":"100964","DOI":"10.1016\/j.preteyeres.2021.100964","volume":"85","author":"SS Hayreh","year":"2021","unstructured":"Hayreh\u00a0SS (2021) Photocoagulation for retinal vein occlusion. Prog Retin Eye Res 85:100964. https:\/\/doi.org\/10.1016\/j.preteyeres.2021.100964","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"1750_CR14","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/s0161-6420(83)34542-5","volume":"90","author":"SS Hayreh","year":"1983","unstructured":"Hayreh\u00a0SS, Rojas\u00a0P, Podhajsky\u00a0P et al (1983) Ocular neovascularization with retinal vascular occlusion-III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology 90(5):488\u2013506. https:\/\/doi.org\/10.1016\/s0161-6420(83)34542-5","journal-title":"Ophthalmology"},{"key":"1750_CR15","doi-asserted-by":"publisher","first-page":"729792","DOI":"10.1155\/2015\/729792","volume":"2015","author":"K Inagaki","year":"2015","unstructured":"Inagaki\u00a0K, Shuo\u00a0T, Katakura\u00a0K (2015) Sublethal photothermal stimulation with a\u00a0micropulse laser induces heat shock protein expression in ARPE-19 cells. J\u00a0Ophthalmol 2015:729792. https:\/\/doi.org\/10.1155\/2015\/729792","journal-title":"J Ophthalmol"},{"issue":"4","key":"1750_CR16","first-page":"240","volume":"17","author":"LE Magargal","year":"1986","unstructured":"Magargal\u00a0LE, Kimmel\u00a0AS, Sanborn\u00a0GE et\u00a0al (1986) Temporal branch retinal vein obstruction: a\u00a0review. Ophthalmic Surg 17(4):240\u2013246 (PMID: 2423940.2)","journal-title":"Ophthalmic Surg"},{"issue":"5","key":"1750_CR17","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/s41433-022-02007-4","volume":"36","author":"L Nicholson","year":"2022","unstructured":"Nicholson\u00a0L, Talks\u00a0SJ, Amoaku\u00a0W et\u00a0al (2022) Retinal vein occlusion (RVO) guideline: executive summary. Eye (Lond) 36(5):909\u2013912. https:\/\/doi.org\/10.1038\/s41433-022-02007-4","journal-title":"Eye (Lond)"},{"issue":"5","key":"1750_CR18","doi-asserted-by":"publisher","first-page":"CD008732","DOI":"10.1002\/14651858.CD008732.pub2","volume":"11","author":"FC Lam","year":"2015","unstructured":"Lam\u00a0FC, Chia\u00a0SN, Lee\u00a0RM (2015) Macular grid laser photocoagulation for branch retinal vein occlusion. Cochrane Database Syst Rev 11(5):CD8732. https:\/\/doi.org\/10.1002\/14651858.CD008732.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1750_CR19","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1111\/aos.12488","volume":"93","author":"A Pielen","year":"2015","unstructured":"Pielen\u00a0A, Mirshahi\u00a0A, Feltgen\u00a0N, RABAMES Study Group et al (2015) Ranibizumab for branch retinal vein occlusion associated macular edema study (RABAMES): six-month results of a\u00a0prospective randomized clinical trial. Acta Ophthalmol 93(1):e29\u201337. https:\/\/doi.org\/10.1111\/aos.12488","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"1750_CR20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.4103\/joco.joco_163_21","volume":"33","author":"M Ouederni","year":"2022","unstructured":"Ouederni\u00a0M, Khalifa\u00a0MBH, Sassi\u00a0H et\u00a0al (2022) Quantitative analysis of microvascular network with optical coherence tomography angiography and its correlation with visual acuity in retinal vein occlusion. J\u00a0Curr Ophthalmol 33(4):453\u2013460. https:\/\/doi.org\/10.4103\/joco.joco_163_21","journal-title":"J Curr Ophthalmol"},{"key":"1750_CR21","unstructured":"Rehak M, Franke A Targeted Laser of areas of nonperfusion in patients with macular edema secondary to central retinal vein occlusion. (under review)"},{"issue":"5","key":"1750_CR22","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00417-013-2528-8","volume":"252","author":"M Rehak","year":"2014","unstructured":"Rehak\u00a0M, Tilgner\u00a0E, Franke\u00a0A et\u00a0al (2014) Early peripheral laser photocoagulation of nonperfused retina improves vision in patients with central retinal vein occlusion (Results of a\u00a0proof of concept study). Graefes Arch Clin Exp Ophthalmol 252(5):745\u2013752. https:\/\/doi.org\/10.1007\/s00417-013-2528-8","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"1750_CR23","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1111\/j.1538-7836.2010.03909.x","volume":"8","author":"M Rehak","year":"2010","unstructured":"Rehak\u00a0M, Wiedemann\u00a0P (2010) Retinal vein thrombosis: pathogenesis and management. J\u00a0Thromb Haemost 8(9):1886\u20131894. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03909.x","journal-title":"J Thromb Haemost"},{"issue":"7","key":"1750_CR24","doi-asserted-by":"publisher","first-page":"CD009510","DOI":"10.1002\/14651858.CD009510.pub3","volume":"7","author":"Z Shalchi","year":"2020","unstructured":"Shalchi\u00a0Z, Mahroo\u00a0O, Bunce\u00a0C et al (2020) Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion. Cochrane Database Syst Rev 7(7):CD9510. https:\/\/doi.org\/10.1002\/14651858.CD009510.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1750_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/IAE.0b013e3182641875","volume":"33","author":"RF Spaide","year":"2013","unstructured":"Spaide\u00a0RF (2013) Prospective study of peripheral panretinal photocoagulation of areas of nonperfusion in central retinal vein occlusion. Retina 33(1):56\u201362. https:\/\/doi.org\/10.1097\/IAE.0b013e3182641875","journal-title":"Retina"},{"issue":"6","key":"1750_CR26","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00347-017-0513-z","volume":"115","author":"M Storch","year":"2018","unstructured":"Storch\u00a0M, Bemme\u00a0S, Rehak\u00a0M et\u00a0al (2018) Ultraweitwinkelangiographie beim retinalen Venenverschluss: Wie gro\u00df ist gro\u00df genug? Ophthalmologe 115(6):499\u2013504. https:\/\/doi.org\/10.1007\/s00347-017-0513-z","journal-title":"Ophthalmologe"},{"issue":"6","key":"1750_CR27","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.ophtha.2016.02.030","volume":"123","author":"R Tadayoni","year":"2016","unstructured":"Tadayoni\u00a0R, Waldstein\u00a0SM, Boscia\u00a0F et al (2016) Individualized stabilization criteria-driven ranibizumab versus laser in branch retinal vein occlusion: six-month results of BRIGHTER. Ophthalmology 123(6):1332\u20131344. https:\/\/doi.org\/10.1016\/j.ophtha.2016.02.030","journal-title":"Ophthalmology"},{"key":"1750_CR28","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1097\/IAE.0b013e31820c83c2","volume":"31","author":"T Terui","year":"2011","unstructured":"Terui\u00a0T, Kondo\u00a0M, Sugita\u00a0T et\u00a0al (2011) Changes in areas of capillary nonperfusion after intravitreal injection of bevacizumab in eyes with branch retinal vein occlusion. Retina 31:1068\u20131074. https:\/\/doi.org\/10.1097\/IAE.0b013e31820c83c2","journal-title":"Retina"},{"issue":"6","key":"1750_CR29","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1097\/IAE.0000000000002126","volume":"39","author":"AS Thomas","year":"2019","unstructured":"Thomas\u00a0AS, Thomas\u00a0MK, Finn\u00a0AP et\u00a0al (2019) Use of the ischemic index on widefield fluorescein angiography to characterize a\u00a0central retinal vein occlusion as ischemic and nonischemic. Retina 39(6):1033\u20131038. https:\/\/doi.org\/10.1097\/IAE.0000000000002126","journal-title":"Retina"},{"key":"1750_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/IAE.0b013e3181e36c6d","volume":"31","author":"I Tsui","year":"2011","unstructured":"Tsui\u00a0I, Kaines\u00a0A, Havunjian\u00a0MA et\u00a0al (2011) Ischemic index and neovascularization in central retinal vein occlusion. Retina 31:105\u2013110. https:\/\/doi.org\/10.1097\/IAE.0b013e3181e36c6d","journal-title":"Retina"},{"key":"1750_CR31","doi-asserted-by":"publisher","first-page":"6641008","DOI":"10.1155\/2021\/6641008","volume":"2021","author":"ME Thomley","year":"2021","unstructured":"Thomley\u00a0ME, Gross\u00a0CN, Preda-Naumescu\u00a0A et al (2021) Real-world outcomes in patients with branch retinal vein occlusion-(BRVO-) related macular edema treated with anti-VEGF injections alone versus anti-VEGF injections combined with focal laser. J\u00a0Ophthalmol 2021:6641008. https:\/\/doi.org\/10.1155\/2021\/6641008","journal-title":"J Ophthalmol"},{"issue":"6","key":"1750_CR32","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.ophtha.2017.01.049","volume":"124","author":"CC Wykoff","year":"2017","unstructured":"Wykoff\u00a0CC, Ou\u00a0WC, Wang\u00a0R, WAVE Study Group et\u00a0al (2017) Peripheral laser for recalcitrant macular edema owing to retinal vein occlusion: the WAVE trial. Ophthalmology 124(6):919\u2013921. https:\/\/doi.org\/10.1016\/j.ophtha.2017.01.049","journal-title":"Ophthalmology"},{"issue":"8","key":"1750_CR33","doi-asserted-by":"publisher","first-page":"737537","DOI":"10.3389\/fmed.2021.737537","volume":"12","author":"Z Zhu","year":"2021","unstructured":"Zhu\u00a0Z, Meng\u00a0Y, Kozak\u00a0I et\u00a0al (2021) Microvascular structure changes after Intravitreal ranibizumab injection in retinal vein occlusion patients with and without macular Ischemia. Front Med 12(8):737537. https:\/\/doi.org\/10.3389\/fmed.2021.737537","journal-title":"Front. Med."},{"key":"1750_CR34","doi-asserted-by":"publisher","first-page":"948852","DOI":"10.3389\/fphar.2022.948852","volume":"13","author":"W Zou","year":"2022","unstructured":"Zou\u00a0W, Du\u00a0Y, Ji\u00a0X et al (2022) Comparison of the efficiency of antiVEGF drugs intravitreal injections treatment with or without retinal laser photocoagulation for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis. Front Pharmacol 13:948852. https:\/\/doi.org\/10.3389\/fphar.2022.948852","journal-title":"Front Pharmacol"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-022-01750-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-022-01750-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-022-01750-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T03:13:44Z","timestamp":1668568424000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-022-01750-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1750"],"URL":"https:\/\/doi.org\/10.1007\/s00347-022-01750-z","relation":{},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"13 October 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Rehak: Beratert\u00e4tigkeit: Allergan, Apellis, Bayer, Novartis, Roche, Zeiss; Referent f\u00fcr Allergan, Alimera, Bayer, Novartis, Roche, Zeiss; Forschungsunterst\u00fctzung (CoRaLa\u00a01 Study): Novartis. Teilnahme an einem Data Safety Monitoring Board oder einem Beratungsgremium: Apellis, Bayer, Novartis, Roche; Leitende oder treuh\u00e4nderische Funktion in einem anderen Vorstand, einer Gesellschaft, einem Ausschuss oder einer Interessengruppe, bezahlt oder unbezahlt: Novartis; Entgegennahme von Ger\u00e4ten, Materialien, Medikamenten, medizinischen Schriften, Geschenken oder anderen Dienstleistungen: Alimera. L.-O.\u00a0Hattenbach: Beratert\u00e4tigkeit: Allergan, Alcon, Bayer, Novartis, Roche, Zeiss; Referent f\u00fcr Bayer, Novartis, Roche, Zeiss. N.\u00a0Feltgen: Beratert\u00e4tigkeit: Allergan, Bayer, Novartis, Roche, Zeiss; Referent f\u00fcr Bayer, Novartis, Roche, Zeiss. M.W.\u00a0Storch gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}